Literature DB >> 1291594

The value of visual evoked potentials in optic neuropathy of Graves' disease.

K Setälä1, C Raitta, M Välimäki, V Katevuo, B A Lamberg.   

Abstract

Visual evoked potentials (VEP) were tested in patients with ophthalmopathy (OP) of Graves' disease (GD) before treatment and half-a-year and 5-7 yr after orbital decompression (7 patients) or retrobulbar irradiation (3 patients). Five patients not requiring treatment for OP and 16 healthy subjects served as controls. Treatment of OP was given on clinical grounds including decreased visual acuity (VA) indicating optic neuropathy. Before treatment VA was decreased in 5 out of 19 eyes whereas VEP were abnormal in all. The mean latency at N60 both in the operated (83.1 +/- 21.6 ms) and in the irradiated groups (80.9 +/- 7.0 ms) was significantly different from that in the untreated group (62.6 +/- 8.2 ms; p < 0.001) and the healthy subjects (58.9 +/- 6.3; p < 0.001). At P120 only the latency of the operated group differed significantly from that of the other groups (p < 0.001). There was a relationship between the eye muscle changes seen on CT scans and the ophthalmopathy score (according to the classification of the American Thyroid Association) and the latency both at N60 and P120. A change from a V-shape to a W-shape of the waves occurred more often in the treated patients before therapy than in the other groups. Two patients had multiphase VEP in both eyes which improved after treatment. After adequate clinical response the visual acuity improved in one of the 5 patients with initially depressed VA. VEP, initially abnormal in all, improved in 7 of the 19 eyes (37%) but further deterioration was observed in 8 (42%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1291594     DOI: 10.1007/BF03348812

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Computed tomography in Graves' ophthalmopathy.

Authors:  D Enzmann; W H Marshal; A R Rosenthal; J P Kriss
Journal:  Radiology       Date:  1976-03       Impact factor: 11.105

2.  Supervoltage orbital radiotherapy for Graves' ophthalmopathy.

Authors:  S S Donaldson; M A Bagshaw; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

3.  Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

Authors:  R M Day; F D Carroll
Journal:  Arch Ophthalmol       Date:  1968-03

Review 4.  Evoked potentials in clinical medicine (second of two parts).

Authors:  K H Chiappa; A H Ropper
Journal:  N Engl J Med       Date:  1982-05-20       Impact factor: 91.245

5.  Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy.

Authors:  S E Feldon; S Muramatsu; J M Weiner
Journal:  Arch Ophthalmol       Date:  1984-10

6.  Pattern EPS in endocrine orbitopathy.

Authors:  R Wijngaarde; G H van Lith
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379

7.  Changes in the electroretinogram and visual evoked potentials during general anaesthesia using enflurane.

Authors:  C Raitta; U Karhunen; A M Seppäläinen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

8.  Dysthyroid optic neuropathy. Clinical profile and rationale for management.

Authors:  J D Trobe; J S Glaser; P Laflamme
Journal:  Arch Ophthalmol       Date:  1978-07

9.  Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography.

Authors:  J S Kennerdell; A E Rosenbaum; M H El-Hoshy
Journal:  Arch Ophthalmol       Date:  1981-05

10.  Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

Authors:  S L Trokel; F A Jakobiec
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

View more
  7 in total

1.  All in the timing.

Authors:  Bryan J Winn
Journal:  Br J Ophthalmol       Date:  2007-04       Impact factor: 4.638

2.  Retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after orbital decompression for dysthyroid optic neuropathy.

Authors:  Xinghua Wang; Fagang Jiang; Shengnan Cheng; Yueqi Yu; Yayan You; Jin Chen; Xiaohuan Pi
Journal:  Int Ophthalmol       Date:  2021-05-04       Impact factor: 2.031

3.  Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  Gennaro Ambrosio; Giuseppe Ferrara; Raffaella Vitale; Rocco De Marco
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

4.  Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy.

Authors:  B Özkan; Ç A Koçer; Ö Altintaş; L Karabaş; A Z Acar; N Yüksel
Journal:  Eye (Lond)       Date:  2016-06-17       Impact factor: 3.775

5.  Electrophysiological Studies in Thyroid Associated Orbitopathy: A Systematic Review.

Authors:  Tiara W U Iao; Shi Song Rong; An Ni Ling; Mårten E Brelén; Alvin Lerrmann Young; Kelvin K L Chong
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

6.  Comparison of 2-wall versus 3-wall orbital decompression against dysthyroid optic neuropathy in visual function: A retrospective study in a Chinese population.

Authors:  Sheng-Nan Cheng; Yue-Qi Yu; Ya-Yan You; Jin Chen; Xiao-Huan Pi; Xing-Hua Wang; Fa-Gang Jiang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

7.  Functional and Morphological Changes in the Visual Pathway in Patients with Graves' Orbitopathy.

Authors:  Agnieszka Jagiełło-Korzeniowska; Agata Bałdys-Waligórska; Alicja Hubalewska-Dydejczyk; Bożena Romanowska-Dixon
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.